Nintedanib Esylate contains Not Less Than 98.0% w/w and Not More Than 102.0% w/w of C31H33N5O4‧C2H6O3S, calculated on the anhydrous basis and solvent free basis.

共有 1 個藥物證書使用此成份

尼達尼布乙磺酸鹽
Nintedanib Esylate

申請商
龍大生技股份有限公司 
適應症
特發性肺纖維化。
含量
發證日期
2020-08-11